loading
Schlusskurs vom Vortag:
$8.91
Offen:
$8.6
24-Stunden-Volumen:
121.32K
Relative Volume:
0.32
Marktkapitalisierung:
$200.92M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-102.09M
KGV:
-8.2952
EPS:
-1.05
Netto-Cashflow:
$-108.72M
1W Leistung:
+18.50%
1M Leistung:
+74.55%
6M Leistung:
+148.86%
1J Leistung:
+31.77%
1-Tages-Spanne:
Value
$8.48
$8.955
1-Wochen-Bereich:
Value
$7.26
$9.10
52-Wochen-Spanne:
Value
$2.2045
$9.10

Dbv Technologies Adr Stock (DBVT) Company Profile

Name
Firmenname
Dbv Technologies Adr
Name
Telefon
33(0)155427878
Name
Adresse
107 AVENUE DE LA REPUBLIQUE, CHATILLON
Name
Mitarbeiter
109
Name
Nächster Verdiensttermin
2024-07-29
Name
Neueste SEC-Einreichungen
Name
DBVT's Discussions on Twitter

Vergleichen Sie DBVT mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
DBVT
Dbv Technologies Adr
8.73 200.92M 0 -102.09M -108.72M -1.05
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
488.84 128.67B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
582.37 60.99B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
599.96 37.03B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
235.63 29.89B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
253.95 26.16B 3.81B -644.79M -669.77M -6.24

Dbv Technologies Adr Stock (DBVT) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2023-01-04 Hochstufung Societe Generale Hold → Buy
2022-12-16 Herabstufung Goldman Neutral → Sell
2022-05-10 Herabstufung Goldman Buy → Neutral
2021-09-14 Hochstufung Societe Generale Hold → Buy
2021-01-22 Herabstufung Societe Generale Hold → Sell
2020-11-02 Hochstufung Societe Generale Sell → Hold
2020-08-06 Herabstufung Societe Generale Buy → Sell
2020-08-05 Bestätigt H.C. Wainwright Buy
2020-03-17 Herabstufung Stifel Buy → Hold
2020-01-09 Hochstufung Stifel Hold → Buy
2019-12-16 Eingeleitet Citigroup Buy
2019-09-05 Fortgesetzt Morgan Stanley Equal-Weight
2019-06-17 Eingeleitet Goldman Buy
2018-12-20 Herabstufung Barclays Overweight → Equal Weight
2018-12-20 Herabstufung BofA/Merrill Buy → Underperform
2018-12-20 Herabstufung Jefferies Buy → Hold
2018-12-20 Herabstufung Stifel Buy → Hold
2017-10-31 Hochstufung Societe Generale Sell → Hold
2017-10-24 Herabstufung Societe Generale Buy → Sell
2017-10-23 Herabstufung Morgan Stanley Overweight → Equal-Weight
2017-06-23 Eingeleitet Deutsche Bank Buy
2017-03-16 Hochstufung Societe Generale Hold → Buy
2016-09-26 Eingeleitet JMP Securities Mkt Outperform
2015-12-03 Eingeleitet Barclays Overweight
2015-10-23 Eingeleitet BofA/Merrill Buy
Alle ansehen

Dbv Technologies Adr Aktie (DBVT) Neueste Nachrichten

pulisher
Apr 17, 2025

DBV Technologies (NASDAQ:DBVT) & Vaxcyte (NASDAQ:PCVX) Critical Contrast - Defense World

Apr 17, 2025
pulisher
Apr 15, 2025

DBV Technologies (NASDAQ:DBVT) Now Covered by Analysts at StockNews.com - Defense World

Apr 15, 2025
pulisher
Apr 12, 2025

DBV Technologies announces filing of 2024 Annual Report on Form 10-K and Universal Registration Document - Informazione.it

Apr 12, 2025
pulisher
Apr 11, 2025

DBV Technologies S.A. SEC 10-K Report - TradingView

Apr 11, 2025
pulisher
Apr 11, 2025

DBV Technologies Completes Dual-Market Financial Filings for 2024 - Stock Titan

Apr 11, 2025
pulisher
Apr 11, 2025

European Equities Traded in the US as American Depositary Receipts Higher in Friday Trading - TradingView

Apr 11, 2025
pulisher
Apr 08, 2025

European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading - TradingView

Apr 08, 2025
pulisher
Apr 07, 2025

European Equities Traded in the US as American Depositary Receipts Drop in Monday Trading - TradingView

Apr 07, 2025
pulisher
Apr 07, 2025

DBV Technologies (NASDAQ:DBVT) Coverage Initiated at StockNews.com - Defense World

Apr 07, 2025
pulisher
Apr 02, 2025

European ADRs Show Mixed Fortunes In US Market - Finimize

Apr 02, 2025
pulisher
Apr 02, 2025

European Equities Traded in the US as American Depositary Receipts Flat in Wednesday Trading - TradingView

Apr 02, 2025
pulisher
Apr 01, 2025

European Equities Traded in the US as American Depositary Receipts Tread Water in Tuesday Trading - TradingView

Apr 01, 2025
pulisher
Mar 30, 2025

DBV Technologies (NASDAQ:DBVT) Coverage Initiated by Analysts at StockNews.com - Defense World

Mar 30, 2025
pulisher
Mar 29, 2025

European ADRs See Mixed Results With Biopharma Leading Gains - Finimize

Mar 29, 2025
pulisher
Mar 28, 2025

Why DBV Technologies (DBVT) Stock Is Skyrocketing - Benzinga

Mar 28, 2025
pulisher
Mar 28, 2025

European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading - TradingView

Mar 28, 2025
pulisher
Mar 28, 2025

US Stocks Likely To Open Lower, Analysts Warn 'Prolonged Uncertainty Could Hurt Both US And Global Risk Assets' - Benzinga

Mar 28, 2025
pulisher
Mar 28, 2025

DBV Technologies announces up to $307M financing to advance Viaskin Peanut program - MSN

Mar 28, 2025
pulisher
Mar 27, 2025

DBV Technologies Announces Financing of up to $306.9 - GlobeNewswire

Mar 27, 2025
pulisher
Mar 27, 2025

Major Breakthrough: $306.9M Funding Powers Revolutionary Peanut Allergy Patch to FDA Finish Line - Stock Titan

Mar 27, 2025
pulisher
Mar 25, 2025

DBV Technologies (NASDAQ:DBVT) vs. Jasper Therapeutics (NASDAQ:JSPR) Head to Head Comparison - Defense World

Mar 25, 2025
pulisher
Mar 24, 2025

European Equities Traded in the US as American Depositary Receipts Higher in Monday Trading - TradingView

Mar 24, 2025
pulisher
Mar 24, 2025

DBV Technologies faces cash shortage, stock drops By Investing.com - Investing.com South Africa

Mar 24, 2025
pulisher
Mar 24, 2025

DBV Technologies faces cash shortage, stock drops - Investing.com

Mar 24, 2025
pulisher
Mar 24, 2025

Major FDA Breakthrough: DBV's Peanut Allergy Treatment Path Accelerates Despite Cash Concerns - Stock Titan

Mar 24, 2025
pulisher
Mar 24, 2025

DBV Technologies Secures Agreement with FDA on Safety - GlobeNewswire

Mar 24, 2025
pulisher
Mar 24, 2025

REG-DBV Technologies Secures Agreement with FDA on Safety Exposure Data Required for BLA for Viaskin® Peanut Patch in 4–7-year-olds, Accelerating the Timeline for a BLA Filing Submission to 1H 2026, & Reports 2024 Unaudited Financial Results... - TradingView

Mar 24, 2025
pulisher
Mar 19, 2025

European Equities Traded in the US as American Depositary Receipts Track Lower in Wednesday Trading - TradingView

Mar 19, 2025
pulisher
Mar 18, 2025

European Equities Traded in the US as American Depositary Receipts Edge Lower in Tuesday Trading - TradingView

Mar 18, 2025
pulisher
Mar 17, 2025

European Equities Traded in the US as American Depositary Receipts Track Higher in Monday Trading - TradingView

Mar 17, 2025
pulisher
Mar 14, 2025

European Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading - MSN

Mar 14, 2025
pulisher
Mar 14, 2025

European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Down for Week - TradingView

Mar 14, 2025
pulisher
Mar 14, 2025

DBV Technologies’ SWOT analysis: peanut allergy patch stock faces crucial trials By Investing.com - Investing.com South Africa

Mar 14, 2025
pulisher
Mar 13, 2025

DBV Technologies’ SWOT analysis: peanut allergy patch stock faces crucial trials - Investing.com

Mar 13, 2025
pulisher
Mar 13, 2025

European Equities Traded in the US as American Depositary Receipts Fall in Monday Trading - MSN

Mar 13, 2025
pulisher
Mar 12, 2025

European Equities Traded in the US as American Depositary Receipts Lower Wednesday - TradingView

Mar 12, 2025
pulisher
Mar 04, 2025

European Equities Traded in the US as ADRs Fall in Tuesday Trading - TradingView

Mar 04, 2025
pulisher
Mar 04, 2025

JMP reiterates DBV Technologies stock with $10 target - Investing.com

Mar 04, 2025
pulisher
Mar 03, 2025

European Equities Traded in the US as American Depositary Receipts Surge Higher in Monday Trading - TradingView

Mar 03, 2025
pulisher
Feb 28, 2025

DBV Technologies (DBVT) Projected to Post Quarterly Earnings on Thursday - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Remain Flat for Week - TradingView

Feb 28, 2025

Finanzdaten der Dbv Technologies Adr-Aktie (DBVT)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Dbv Technologies Adr-Aktie (DBVT) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Mohideen Pharis
Chief Medical Officer
Nov 25 '24
Sale
0.57
565
322
111,110
Mohideen Pharis
Chief Medical Officer
Nov 22 '24
Sale
0.53
342
181
111,675
Mohideen Pharis
Chief Medical Officer
Nov 21 '24
Sale
0.54
2,350
1,269
112,017
Mohideen Pharis
Chief Medical Officer
Jul 29 '24
Sale
0.98
1,785
1,749
79,367
Mohideen Pharis
Chief Medical Officer
May 24 '24
Sale
1.36
660
898
81,152
Mohideen Pharis
Chief Medical Officer
May 22 '24
Sale
1.38
382
527
81,812
$19.80
price down icon 1.75%
$70.30
price up icon 2.22%
$32.51
price up icon 0.87%
$26.24
price up icon 1.84%
$102.53
price down icon 0.01%
biotechnology ONC
$248.35
price up icon 8.46%
Kapitalisierung:     |  Volumen (24h):